Modification of Alpha-Crystallin Chaperone Function
α-晶状体蛋白伴侣功能的修饰
基本信息
- 批准号:6931038
- 负责人:
- 金额:$ 31.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-06-01 至 2008-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): aA- and aB-crystallins in which different number of C-terminal residues have been deleted are present in human and rat lenses. These are aA1-172, aA1-168, aA1-162, aB1-174, and aB1-170 in human lenses and aA1-168, aA1-163, aA1-162, aA1-157, aA1-151 and aB1-170 in rat lenses. We have shown increased levels of the truncated aA- and aB-crystallins in diabetic human and rat lenses. We have shown that rat aA1-168 and aA1-163 have nearly normal chaperone activity and oligomeric size whereas aA1-162, aA1-157, and aA-151 have lost 60-100% chaperone activity and their oligomeric size decreased 75%. Human aA1-172 has lost 40% chaperone activity with no change in oligomeric size. It is noteworthy that cleavage of Arg-163, which forms aA1-162 resulted in substantial decrease in oligomeric size. Truncated aA- and aB-crystallins could be present in the lens mainly as homoaggregates and as heteroaggregates with normal aA and aB. So, the chaperone function, structure and oligomeric size will be influenced by the formation of various forms of aggregates. The relative strength of the homointeractions and heterointeractions will dictate the level of the various forms of aggregates. This proposal is aimed: 1) to explore the role of Arg-163 in the oligomerization of human and rat aA- and aB-crystallins by generating and characterizing site-directed mutants of Arg-163, 2) to study the effect of truncations of C-terminal residues of human and rat aA- and aB-crystallins while the mutants exist in the form of homo-aggregates and heteroaggregates, 3)to study the homogeneous and heterogeneous interactions of
the truncated mutants by determining the rates of subunit exchange using fluorescence resonance energy transfer, and 4) to determine the extent of homogeneous and heterogeneous interactions of the truncated mutants in vivo utilizing a mammalian two-hybrid assay. These studies are expected to show the consequence of the generation of the various aA- and aB-crystallin C-terminal truncated mutants and how it could influence lens pathology, in diabetic lenses in particular.
描述(由申请人提供):人类和大鼠晶状体中存在不同数量的c端残基被删除的aA-和ab -晶体蛋白。人晶状体为a1 -172、a1 -168、a1 -162、a1 -174和a1 -170,大鼠晶状体为a1 -168、a1 -163、a1 -162、a1 -157、a1 -151和a1 -170。我们发现,在糖尿病人和大鼠晶状体中,截断的aA-和ab -晶体蛋白水平增加。我们已经证明大鼠a1 -168和a1 -163具有接近正常的伴侣活性和寡聚物大小,而a1 -162、a1 -157和aA-151失去了60-100%的伴侣活性,其寡聚物大小减少了75%。人类a1 -172失去了40%的伴侣活性,寡聚物大小没有变化。值得注意的是,Arg-163的裂解形成a1 -162,导致寡聚物尺寸大幅减小。截短的aA-和aB-晶体蛋白在晶状体中主要以同聚集体和异聚集体的形式存在,与正常的aA和aB存在异聚集体。因此,不同形式聚集体的形成会影响伴侣蛋白的功能、结构和寡聚物的大小。同质相互作用和异质相互作用的相对强度决定了各种形式聚集体的水平。本课题旨在:1)通过生成和表征Arg-163位点定向突变体,探索Arg-163在人和大鼠aA-和ab -结晶蛋白寡聚化中的作用;2)研究突变体以同质聚集体和异质聚集体形式存在时,人和大鼠aA-和ab -结晶蛋白c端残基截断的影响
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edathara C Abraham其他文献
Edathara C Abraham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edathara C Abraham', 18)}}的其他基金
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
6126661 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
Modification of Alpha-Crystallin Chaperone Function
α-晶状体蛋白伴侣功能的修饰
- 批准号:
6770724 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
Modification of Alpha-Crystallin Chaperone Function
α-晶状体蛋白伴侣功能的修饰
- 批准号:
8197593 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
6384662 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
2165678 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
2430394 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
Modification of Alpha-Crystallin Chaperone Function
α-晶状体蛋白伴侣功能的修饰
- 批准号:
8374126 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
6635645 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
6518548 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
MODIFICATION OF ALPHA-CRYSTALLIN CHAPERONE FUNCTION
α-晶状体蛋白伴侣功能的修饰
- 批准号:
2888498 - 财政年份:1996
- 资助金额:
$ 31.2万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 31.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 31.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 31.2万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 31.2万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:
Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 31.2万 - 项目类别:














{{item.name}}会员




